Filing Details

Accession Number:
0001104659-20-083455
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-07-14 16:46:23
Reporting Period:
2020-07-10
Accepted Time:
2020-07-14 16:46:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1744659 Akero Therapeutics Inc. AKRO () E9
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1593440 Apple Tree Partners Iv, L.p. C/o Akero Therapeutics, Inc.,
601 Gateway Boulevard, Suite 350
South San Francisco CA 94080
No No Yes No
1593453 Atp Iii Gp, Ltd. C/o Akero Therapeutics, Inc.,
601 Gateway Boulevard, Suite 350
South San Francisco CA 94080
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-07-10 415,000 $36.00 5,830,203 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. On July 10, 2020, Apple Tree Partners, IV, L.P. ("ATP") purchased 415,000 shares of common stock of the Issuer at a price of $36.00 per share pursuant to an underwritten public offering.
  2. These shares are owned directly by ATP. ATP III GP, Ltd. ("ATP GP") is the sole general partner of ATP. Seth L. Harrison is a director on the Issuer's board of directors and is the sole director of ATP GP. ATP GP disclaims beneficial ownership of the shares listed, except to the extent of its pecuniary interest therein.